Recombinant Protein Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global recombinant protein market size reached US$ 170.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 279.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.4% during 2023-2028.
A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.
Recombinant Protein Market Trends:
The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant protein market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Antibodies
Hormones
Growth Factors
Cytokines
Others
Breakup by Application:
Drug Discovery and Development
Academic Research
Biotechnology Research
Biopharmaceutical Production
Others
Breakup by End User:
Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.
Key Questions Answered in This Report:
How has the global recombinant protein market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global recombinant protein market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global recombinant protein market and who are the key players?
What is the degree of competition in the industry?
A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.
Recombinant Protein Market Trends:
The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant protein market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Antibodies
Hormones
Growth Factors
Cytokines
Others
Breakup by Application:
Drug Discovery and Development
Academic Research
Biotechnology Research
Biopharmaceutical Production
Others
Breakup by End User:
Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.
Key Questions Answered in This Report:
How has the global recombinant protein market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global recombinant protein market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global recombinant protein market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL RECOMBINANT PROTEIN MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hormones
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Growth Factors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytokines
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Drug Discovery and Development
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Academic Research
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biotechnology Research
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Biopharmaceutical Production
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Pharmaceutical and Biopharmaceutical Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Biotechnology Companies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Contract Research Organization
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abcam plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bio-Techne Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bps Bioscience Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Enzo Biochem Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Genscript Biotech Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Novo Nordisk A/S
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 ProSpec-Tany TechnoGene Ltd
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sanofi S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL RECOMBINANT PROTEIN MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hormones
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Growth Factors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytokines
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Drug Discovery and Development
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Academic Research
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biotechnology Research
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Biopharmaceutical Production
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Pharmaceutical and Biopharmaceutical Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Biotechnology Companies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Contract Research Organization
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abcam plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bio-Techne Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bps Bioscience Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Enzo Biochem Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Genscript Biotech Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Novo Nordisk A/S
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 ProSpec-Tany TechnoGene Ltd
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sanofi S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Recombinant Protein Market: Competitive Structure
Table 7: Global: Recombinant Protein Market: Key Players
Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Recombinant Protein Market: Competitive Structure
Table 7: Global: Recombinant Protein Market: Key Players
LIST OF FIGURES
Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2022
Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2022
Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2022
Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2022
Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2022
Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis
Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2022
Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2022
Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2022
Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2022
Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2022
Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis
